TP53 mutations in somatic cells are observed in about 50% of human cancers, but the frequency and type of mutation varies from one tumor to another and can be exchange of sense, nonsense, deletion, insertion, or splicing mutations [39,40]. The gene discussed is TP53; the disease is cancer.